EUVIMEDEUVIMED entdecken
Crossref

Double-Lock Superpolymer TDN is Used for the Theranostics of HCC

Chengyun Dou, Chuyue Liao, Junyi Liu, Xia Xie, Mengying Tang, Chuangjie Cao iD

Analytical Chemistry · 10.11.2026 · 98 (44) · 30152-30160

DOI: 10.1021/acs.analchem.6c00899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 07.10.2026. Verfasst von Chengyun Dou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, the First Affiliated Hospital of University of South China, Hengyang Medical School, University of South China, He…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Theranostic Nanomedicine. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is difficult to diagnose early and treat effectively due to its heterogeneity and lack of highly specific biomarkers. Here, we develop a double-lock superpolymer tetrahedral DNA (TDN) integrated with small extracellular vesicles (SUPDIA) for HCC theranostics. The TDN incorporates an HSP70 aptamer and a miR-21 complementary sequence, both initially blocked to form a locked state. Upon dual-target recognition of HSP70 and miR-21, two sticky ends are exposed, inducing TDN super-assembly into superpolymers with aggregated Cy5 fluorescence and concurrent miR-21 sequestration. This system enables dual-target-dependent signal amplification, achieving specific HSP70 detection with a 0.01#x2212;10 ng/mL linear range and a 0.001 ng/mL detection limit. HepG2 cell-derived small extracellular vesicles (sEVs) are used to encapsulate TDNs, conferring homotypic targeting, caveolin-dependent uptake, lysosomal escape, and deep penetration in 3D spheroids. In vivo, SUPDIA shows enhanced fluorescence in HCC xenografts and superior imaging versus non-aggregating controls, while effectively downregulating miR-21, inhibiting angiogenesis, and reducing cell viability. This exosome-delivered TDN superpolymer offers a precise, biomarker-guided platform for integrated HCC diagnosis and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularTheranostic NanomedicineHumansMicroRNAsAnimalsMiceHep G2 CellsDNA NanostructuresHSP70 Heat-Shock ProteinsAptamers, NucleotideMice, NudePolymersCarbocyaninesExtracellular Vesicles

Substanzen

MicroRNAsMIRN21 microRNA, humanHSP70 Heat-Shock ProteinsAptamers, NucleotidePolymersCarbocyaninescyanine dye 5

Autor:innen und Institutionen

  • Department of Infectious Diseases, the First Affiliated Hospital of University of South China, Hengyang Medical School, University of South China, Hengyang, Hunan Province421001, China.
  • Hengyang Medical School, University of South China, Hengyang, Hunan Province421001, China.
  • Department of Pathology, the First Affiliated Hospital of University of South China, Hengyang Medical School, University of South China, Hengyang, Hunan Province421001, China.

ORCID-Profile: Chuangjie Cao

Förderung

  • Natural Science Foundation of Hunan Province

Zitieren

APA

Dou, C., Liao, C., Liu, J., Xie, X., Tang, M., & Cao, C. (2026). Double-Lock Superpolymer TDN is Used for the Theranostics of HCC. Analytical Chemistry, 98(44), 30152-30160. https://doi.org/10.1021/acs.analchem.6c00899

Vancouver

Dou C, Liao C, Liu J, Xie X, Tang M, Cao C. Double-Lock Superpolymer TDN is Used for the Theranostics of HCC. Analytical Chemistry. 2026;98(44):30152-30160. doi:10.1021/acs.analchem.6c00899

BibTeX
@article{Dou2026,
  author = {Dou, Chengyun and Liao, Chuyue and Liu, Junyi and Xie, Xia and Tang, Mengying and Cao, Chuangjie},
  title = {Double-Lock Superpolymer TDN is Used for the Theranostics of HCC},
  journal = {Analytical Chemistry},
  year = {2026},
  volume = {98},
  number = {44},
  pages = {30152--30160},
  doi = {10.1021/acs.analchem.6c00899}
}
Kostenlos starten →